Mobia Medical MOBI

Mobia Medical, Inc. is a commercial stage medical device company focused on stroke recovery. Its Vivistim Paired Vagus Nerve Stimulation System is the first and only FDA approved solution for chronic ischemic stroke survivors with moderate to severe upper extremity impairments. The system delivers timed bursts of vagus nerve stimulation during functional movement to enhance neuroplasticity and restore motor function. The company operates in the medical device industry within the neurorehabilitation segment.

Mobia Medical generates revenue primarily from the sale of the Vivistim System which includes an implanted pulse generator and lead as well as associated accessories. The company sells the system to stroke hospitals and therapy sites in the United States. Revenue is recognized upon implantation and delivery of the device. For the year ended December 31 2025 the company reported revenue of thirty two million dollars representing year over year growth of one hundred four point eight percent from fifteen point six million dollars in the prior year.

Mobia Medical holds a unique position as the first and only FDA approved device for chronic ischemic stroke upper extremity recovery. The company faces no direct competitors offering a similar paired vagus nerve stimulation therapy. Its competitive advantages include a robust patent portfolio covering electrode technology and stimulation methods breakthrough device designation from the FDA and a newly assigned New Technology Ambulatory Payment Classification that provides elevated Medicare reimbursement. The clinical evidence from pivotal and real world studies demonstrates durable functional gains and a favorable safety profile.

Mobia Medical’s customer base consists of stroke hospitals therapy sites physicians and ultimately patients living with chronic stroke impairment. The company targets approximately one thousand five hundred primary and comprehensive stroke centers across the United States. These centers are supported by networks of outpatient therapy facilities that deliver Vivistim Therapy. Specific customer names are not disclosed in the filing.